Your browser doesn't support javascript.
loading
Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.
Maynadier, Marie; Basile, Ilaria; Gallud, Audrey; Gary-Bobo, Magali; Garcia, Marcel.
Affiliation
  • Maynadier M; Institut des Biomolécules Max Mousseron (IBMM), CNRS, Université Montpellier, ENSCM, Faculté de Montpellier, 34093 Montpellier Cedex 5, France.
  • Basile I; Institut des Biomolécules Max Mousseron (IBMM), CNRS, Université Montpellier, ENSCM, Faculté de Montpellier, 34093 Montpellier Cedex 5, France.
  • Gallud A; Institut des Biomolécules Max Mousseron (IBMM), CNRS, Université Montpellier, ENSCM, Faculté de Montpellier, 34093 Montpellier Cedex 5, France.
  • Gary-Bobo M; Institut des Biomolécules Max Mousseron (IBMM), CNRS, Université Montpellier, ENSCM, Faculté de Montpellier, 34093 Montpellier Cedex 5, France.
  • Garcia M; Institut des Biomolécules Max Mousseron (IBMM), CNRS, Université Montpellier, ENSCM, Faculté de Montpellier, 34093 Montpellier Cedex 5, France.
Oncol Rep ; 36(2): 1127-34, 2016 Aug.
Article in En | MEDLINE | ID: mdl-27373750

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Proteasome Endopeptidase Complex Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Proteasome Endopeptidase Complex Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: France